Table 1. Anti PD-1/PD-L1 antibodies and companion/complementary diagnostic PD-L1 IHC assays.
Antibody | Pembrolizumab | Nivolumab | Atezolizumab | Durvalumab | Avelumab |
---|---|---|---|---|---|
Target | PD-1 | PD-1 | PD-L1 | PD-L1 | PD-L1 |
Clone used for assay | 22C3 | 28-8 | SP142 | SP263 | 73-10 |
Company | Dako | Dako | Ventana | Ventana | Dako |
PD-1, programmed cell death 1; PD-L1, programmed cell death ligand 1.